📋 FDA Reference

Philips CT 3500

Philips Healthcare (Suzhou)

Compare similar devices

Summary: The Philips CT 3500 is a medical imaging device used for diagnostic purposes in various clinical settings. It is primarily utilized by radiologists and healthcare professionals specializing in imaging.

FDA Clearance Information

Pathway ? 510(k)
Number ? K223311 ↗
Decision Date ? December 22, 2022
Product Code ? JAK
Device Class ? Class 2
Evidence ? 419 studies

The Philips CT 3500 was cleared through the FDA 510(k) pathway on December 22, 2022. Manufactured by Philips Healthcare (Suzhou), it is classified as a Class 2 device under product code JAK.

What It Is

The Philips CT 3500 is a computed tomography (CT) scanner designed to produce detailed cross-sectional images of the body. It uses X-ray technology to capture images that can be reconstructed into 3D models, aiding in the diagnosis of various conditions. The device is equipped with advanced imaging capabilities to enhance image quality and reduce scan times, making it a valuable tool in modern medical diagnostics.

FDA-Cleared Indications

  • Diagnostic imaging of the body to assist in evaluating medical conditions.
  • Acquisition of cross-sectional images for detailed anatomical visualization.
  • Use in procedures requiring imaging assessment associated with embolization liquid agents.

Clinical Applications

  • Diagnostic CT imaging of relevant body regions when cross-sectional anatomical information is needed.
  • Imaging assessment associated with procedures using embolization liquid agents.
  • Image reconstruction and review to support clinical evaluation and treatment planning.

Reported off-label uses

  • CT angiography for evaluation of blood vessels when performed under an appropriate clinical protocol.
  • CT-guided needle placement or biopsy when the scanner and facility are configured for that purpose.
  • CT-based treatment planning in oncology and radiation therapy.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The scanner uses ionizing radiation; protocols should be adjusted to the patient, examination, and clinical question.
  • The device is not MRI equipment and is not used for MRI examinations. MRI safety considerations apply to any external equipment brought into the MRI room.
  • Patient weight, body size, positioning, and ability to remain still must be assessed against the system specifications and examination protocol.
  • Iodinated contrast may be used for some CT examinations, but contrast administration requires assessment of allergy history, kidney function, pregnancy status, and other contraindications.
  • The system should be operated by trained personnel according to the manufacturer's instructions and the facility's quality-assurance procedures.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is Philips CT 3500 used for?

The Philips CT 3500 is used for diagnostic imaging to produce detailed cross-sectional images of the body, aiding in the diagnosis of various medical conditions.

What specialties typically use this device?

Radiologists and healthcare professionals specializing in medical imaging commonly use this device in hospitals and imaging centers.

What are the FDA-cleared indications?

The device is indicated for diagnostic imaging, particularly in procedures requiring detailed anatomical visualization, such as those involving embolization-liquid-agents.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you